Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
The Bioequivalence studies were performed to compare the rate and extent of release of the
drug substance from the two Capsule formulations containing Venlafaxine Hydrochloride
Extended-Release Capsules 150mg of Torrent Pharmaceuticals Limited and the Effexor XR®
(Venlafaxine Hydrochloride) Extended-Release Capsules 150mg of Wyeth Pharmaceuticals Inc.,
USA.
Study Design:
Open Label, Randomised, Two Period, Two Treatment, Two Sequence, Crossover, Single-Dose
Bioequivalence Study of Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test
formulation, Torrent Pharmaceutical Limited., India) Versus Effexor XR® 150mg capsule
(Reference formulation, Wyeth Pharmaceuticals Inc., USA) in Healthy Volunteers